Zhejiang Jingxin Pharmaceutical Co.,Ltd.’s Net Profit Rose 8.1% in 2022

Zhejiang Jingxin Pharmaceutical Co.,Ltd. (浙江京新药业股份有限公司) (002020.SZ) reported a net profit of 667.8 million yuan in 2022, up 8.1% year-on-year.
Meanwhile, the company posted 3.8 billion yuan in revenue, up 9% year-on-year.
At the end of the reporting period, it had 7.4 billion yuan in total assets and 2.2 billion yuan in total liabilities, with a liability-to-asset ratio of 29.8%.
- PODCAST
- MOST POPULAR